Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review PLXNB1 (plexin B1) José Javier Gómez-Román, Montserrat Nicolas Martínez, Servando Lazuén Fernández, José Fernando Val-Bernal Department of Anatomical Pathology, Marques de Valdecilla University Hospital, Medical Faculty, University of Cantabria, Santander, Spain (JJGR, MN, SL, JFVB) Published in Atlas Database: March 2009 Online updated version: http://AtlasGeneticsOncology.org/Genes/PLXNB1ID43413ch3p21.html DOI: 10.4267/2042/44702 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2010 Atlas of Genetics and Cytogenetics in Oncology and Haematology Pseudogene Identity No. Other names: KIAA0407; MGC149167; OTTHUMP00000164806; PLEXIN-B1; PLXN5; SEP HGNC (Hugo): PLXNB1 Location: 3p21.31 Local order: The Plexin B1 gene is located between FBXW12 and CCDC51 genes. Protein Description 2135 Amino acids (AA). Plexins are receptors for axon molecular guidance molecules semaphorins. Plexin signalling is important in pathfinding and patterning of both neurons and developing blood vessels. Plexin-B1 is a surface cell receptor. When it binds to its ligand SEMA4D it activates several pathways by binding of cytoplasmic ligands, like RHOA activation and subsequent changes of the actin cytoskeleton, axon guidance, invasive growth and cell migration. It monomers and heterodimers with PLXNB2 after proteolytic processing. Binds RAC1 that has been activated by GTP binding. It binds PLXNA1 and by similarity ARHGEF11, ARHGEF12, ERBB2, MET, MST1R, RND1, NRP1 and NRP2. This family features the C-terminal regions of various plexins. The cytoplasmic region, which has been called a SEX domain in some members of this family is involved in downstream signalling pathways, by interaction with proteins such as Rac1, RhoD, Rnd1 and other plexins. Three copies of a cysteine rich repeat are found in Plexin. The function of the repeat is unknown. Note Size: 26,200 bases. Orientation: minus strand. DNA/RNA Description Functioning gene. 21.00 kb; 37 Exons. Transcription 7097.00 bp; Number of transcripts: 1; Type: Messenger. Two alternatively truncated spliced variant, coding secreted proteins (lacking the part of the extracellular domains). Atlas Genet Cytogenet Oncol Haematol. 2010; 14(3) Expression It is highly expressed in fetal kidney, digestive system (from esophagus to colon), thyroid, prostate and trachea and at slightly lower levels in fetal brain, lung, female reproductive system (breast, uterus and ovary) and liver. 249 PLXNB1 (plexin B1) Gómez-Román JJ, et al. Plexin B1 policlonal antibody in foetal human central nervous system. Positive staining in developing neurons. mutations in the cytoplasmic domain of the PLXNB1 gene in prostate cancer tissue. Mutations were found in 8 (89%) of 9 prostate cancer bone metastases, in 7 (41%) of 17 lymph node meta-stases, and in 41 (46%) of 89 primary cancers. Forty percent of prostate cancers contained the same mutation, and the majority of the primary tumors showed overexpression of the plexinB1 protein. In vitro functional expression studies of the 3 most common mutations showed that the mutant proteins resulted in increased cell motility, inva-sion, adhesion, and lamellipodia extension compared to wildtype. The mutations acted by hindering RAC1 and RRAS binding and GTP activity. Localisation Three isoforms have been identified: The isoform 1 is located in cell membrane and the isoforms 2 and 3 are secreted proteins. Function Plexin B1 has several molecular functions, like a receptor activity, transmembrane receptor activity, protein binding, semaphorin receptor and semaphorin receptor binding. It is implicated in the next biological processes: Signal transduction, intracellular signalling cascade, multicellular organismal development, cell migration and posi-tive regulation of axonogenesis. Homology Implicated in It belongs to the plexin family and it contains 3 IPT/TIG domains and one Sema domain. Breast cancer Prognosis Loss of protein Plexin B1 expression is associated with poor outcome in breast cancer ER (estrogen positive) patients. Mutations Somatic Wong et al. (2007) identified 13 different somatic Atlas Genet Cytogenet Oncol Haematol. 2010; 14(3) 250 PLXNB1 (plexin B1) Gómez-Román JJ, et al. Renal cell carcinoma Prostate carcinoma Note By reverse transcription-polymerase chain reaction Note 13 somatic missense mutations in the cytoplasmic domain of the Plexin-B1 gene have been reported. Mutations were found in cancer bone metastases, lymph node metastases, and in primary cancers. Forty percent of prostate cancers contained the same mutation. Overexpression of the Plexin-B1 protein was found in the majority of primary tumors. The mutations hinder Rac and R-Ras binding and R-RasGAP activity, resulting in an increase in cell motility, invasion, adhesion, and lamellipodia. plexin B1 is expressed in nonneoplastic renal tissue, and it is severely downregulated in clear cell renal carcinomas. By immunohistochemistry on tissue microarrays it was shown that plexin B1 protein is absent in more than 80% of renal cell carcinomas. Otherwise, all kinds of renal tubules showed strong membrane reactivity. When plexin B1 expression is induced with an expression vector in the renal adenocarcinoma cell line ACHN, a marked reduction in proliferation rate is found. Plexin B1 in normal kidney tissue. Tubular cortical and medular cells reactive The same immunostaining after blocking peptide incubation. Atlas Genet Cytogenet Oncol Haematol. 2010; 14(3) 251 PLXNB1 (plexin B1) Gómez-Román JJ, et al. Plexin B1 loss of expression in three cases of renal cell carcinoma (clear cell upper right and left), and papillary (bottom right). One case of renal clear cell carcinoma with PlexinB1 expression (bottom left). Osteoarthritis activation by Plexin-B1 and induces cell contraction in COS-7 cells. J Biol Chem. 2003 Jul 11;278(28):25671-7 Note Using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis, plexin B1 (PLXNB1) was confirmed to be consis-tently expressed at lower levels in osteoarthritis. Disease Degenerative bone disease. Usui H, Taniguchi M, Yokomizo T, Shimizu T. Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains. Biochem Biophys Res Commun. 2003 Jan 24;300(4):927-31 Conrotto P, Corso S, Gamberini S, Comoglio PM, Giordano S. Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene. 2004 Jul 1;23(30):5131-7 Oinuma I, Ishikawa Y, Katoh H, Negishi M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for RRas. Science. 2004 Aug 6;305(5685):862-5 References Swiercz JM, Kuner R, Offermanns S. Plexin-B1/RhoGEFmediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J Cell Biol. 2004 Jun 21;165(6):869-80 Maestrini E, Tamagnone L, Longati P, Cremona O, Gulisano M, Bione S, Tamanini F, Neel BG, Toniolo D, Comoglio PM. A family of transmembrane proteins with homology to the METhepatocyte growth factor receptor. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):674-8 Torres-Vázquez J, Gitler AD, Fraser SD, Berk JD, Van N Pham, Fishman MC, Childs S, Epstein JA, Weinstein BM. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell. 2004 Jul;7(1):117-23 Fujii T, Nakao F, Shibata Y, Shioi G, Kodama E, Fujisawa H, Takagi S. Caenorhabditis elegans PlexinA, PLX-1, interacts with transmembrane semaphorins and regulates epidermal morphogenesis. Development. 2002 May;129(9):2053-63 Basile JR, Afkhami T, Gutkind JS. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol. 2005 Aug;25(16):6889-98 Lorenzato A, Olivero M, Patanè S, Rosso E, Oliaro A, Comoglio PM, Di Renzo MF. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 2002 Dec 1;62(23):7025-30 Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F, Giordano S. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood. 2005 Jun 1;105(11):4321-9 Oinuma I, Katoh H, Harada A, Negishi M. Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho Atlas Genet Cytogenet Oncol Haematol. 2010; 14(3) 252 PLXNB1 (plexin B1) Gómez-Román JJ, et al. Basile JR, Gavard J, Gutkind JS. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J Biol Chem. 2007 Nov 30;282(48):34888-95 B1 and the small GTPase Rac1. J Mol Biol. 2008 Apr 11;377(5):1474-87 Gómez Román JJ, Garay GO, Saenz P, Escuredo K, Sanz Ibayondo C, Gutkind S, Junquera C, Simón L, Martínez A, Fernández Luna JL, Val-Bernal JF. Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth. Transl Res. 2008 Mar;151(3):134-40 Harduf H, Goldman S, Shalev E. Human uterine epithelial RL95-2 and HEC-1A cell-line adhesiveness: the role of plexin B1. Fertil Steril. 2007 Jun;87(6):1419-27 Tong Y, Chugha P, Hota PK, Alviani RS, Li M, Tempel W, Shen L, Park HW, Buck M. Binding of Rac1, Rnd1, and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain. J Biol Chem. 2007 Dec 21;282(51):37215-24 Swiercz JM, Worzfeld T, Offermanns S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J Biol Chem. 2008 Jan 25;283(4):1893-901 Tong Y, Hota PK, Hamaneh MB, Buck M. Insights into oncogenic mutations of plexin-B1 based on the solution structure of the Rho GTPase binding domain. Structure. 2008 Feb;16(2):246-58 Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, Constantinou J, Feneley MR, Klocker H, Eccles SA, Negishi M, Freeman A, Masters JR, Williamson M. Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19040-5 This article should be referenced as such: Gómez-Román JJ, Nicolas Martínez M, Lazuén Fernández S, Val-Bernal JF. PLXNB1 (plexin B1). Atlas Genet Cytogenet Oncol Haematol. 2010; 14(3):249-253. Bouguet-Bonnet S, Buck M. Compensatory and long-range changes in picosecond-nanosecond main-chain dynamics upon complex formation: 15N relaxation analysis of the free and bound states of the ubiquitin-like domain of human plexin- Atlas Genet Cytogenet Oncol Haematol. 2010; 14(3) 253